Comparative Pharmacology
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus M V I 12 LYOPHILIZED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I ADULT PHARMACY BULK PACKAGE versus M V I 12 LYOPHILIZED.
M.V.I. ADULT (PHARMACY BULK PACKAGE) vs M.V.I.-12 LYOPHILIZED
Head-to-head clinical comparison of therapeutic indices and safety profiles.
M.V.I. Adult is a multivitamin formulation providing essential vitamins that serve as cofactors in various enzymatic reactions and metabolic pathways. Vitamin A is essential for vision and cell differentiation; B vitamins (B1, B2, B3, B5, B6, B7, B9, B12) act as coenzymes in energy metabolism, red blood cell production, and nerve function; Vitamin C is an antioxidant and cofactor for collagen synthesis; Vitamin D regulates calcium homeostasis; Vitamin E is an antioxidant; and Vitamin K is required for hepatic synthesis of clotting factors.
Provides essential vitamins for normal metabolic function, acting as cofactors in enzymatic reactions, including energy production, red blood cell synthesis, and antioxidant defense.
FDA-approved: Prevention and treatment of vitamin deficiencies in adults requiring parenteral nutrition.Off-label: Correction of vitamin deficiencies in patients unable to tolerate oral intake; perioperative vitamin supplementation.
FDA-approved for the prevention and treatment of vitamin deficiencies in patients requiring parenteral nutrition.
10 mL intravenously once daily, added to 500 mL of compatible infusion fluid and administered over 8-24 hours.
10 mL (one vial) intravenously once daily, infused over at least 30 minutes.
None Documented
None Documented
Variable; thiamine (B1) ~9-18 min; riboflavin (B2) ~66-84 min; pyridoxine (B6) ~15-20 days; ascorbic acid (C) ~16-20 days (in deficiency states) or ~10-14 days (normal); retinol (A) ~2-3 days; ergocalciferol (D2) ~19-48 hours; alpha-tocopherol (E) ~40-60 hours; phytonadione (K1) ~1-2 hours.
Variable by vitamin: thiamine ~24h, riboflavin ~18h, pyridoxine ~30h, cyanocobalamin ~6 days, ascorbic acid ~8h, retinol ~20h, ergocalciferol ~19 days, alpha-tocopherol ~10h, phytonadione ~4h. Clinical context: short t1/2 of water-soluble vitamins requires daily dosing; long t1/2 of fat-soluble vitamins allows less frequent dosing but risk of accumulation.
Vitamins are metabolized mainly in the liver via conjugation or transformation; water-soluble vitamins are excreted renally; fat-soluble vitamins (A, D, E, K) are stored in tissues and undergo enterohepatic circulation.
Vitamins are metabolized via various pathways in the liver and tissues, including phosphorylation, dephosphorylation, and oxidation-reduction reactions.
Renal excretion of water-soluble vitamins (B-complex, C); bile/fecal elimination of fat-soluble vitamins (A, D, E, K). Approximate percentages: Vitamins B1, B2, B6, C: >90% renal; Vitamin A: 70% fecal, 30% renal metabolites; Vitamin D: 75% fecal, 25% renal; Vitamin E: >60% fecal; Vitamin K: 50% fecal, 50% renal.
Renal: water-soluble vitamins (B-complex, C) are excreted primarily via kidneys, with excess eliminated unchanged. Fat-soluble vitamins (A, D, E, K) are eliminated via bile and feces; renal excretion is minimal. Specific percentages: thiamine 80-90% renal, riboflavin 60-70% renal, pyridoxine 70-80% renal, cyanocobalamin 50-60% renal, ascorbic acid 60-70% renal; fat-soluble vitamins >90% biliary/fecal.
Thiamine: 90% bound to albumin; Riboflavin: 60% bound; Pyridoxine: 70-80% bound; Ascorbic acid: 25% bound; Retinol: 95% bound to retinol-binding protein; Calciferol: 85-90% bound to vitamin D-binding protein; Tocopherol: >90% bound to lipoproteins; Phylloquinone: 99% bound to lipoproteins.
Variable: thiamine ~10% bound to albumin; riboflavin ~30% bound to albumin; pyridoxine ~60% bound to albumin; cyanocobalamin bound to transcobalamins (~20%); ascorbic acid ~5% bound; retinol bound to retinol-binding protein (RBP) ~100%; ergocalciferol bound to vitamin D-binding protein (DBP) ~90%; alpha-tocopherol bound to lipoproteins ~90%; phytonadione bound to lipoproteins ~95%.
Water-soluble vitamins: 0.5-1.0 L/kg (total body water); fat-soluble vitamins: 5-10 L/kg (extensive tissue storage). Clinical meaning: High Vd for fat-soluble vitamins indicates large tissue reservoirs.
Extensive for fat-soluble vitamins: retinol ~5 L/kg, ergocalciferol ~10 L/kg, alpha-tocopherol ~10 L/kg; water-soluble vitamins have Vd approximating total body water: thiamine ~0.6 L/kg, riboflavin ~0.5 L/kg, ascorbic acid ~0.4 L/kg. Clinical meaning: large Vd indicates extensive tissue distribution and storage.
IV: 100% bioavailability. Not administered orally via this product.
Intravenous: 100%. No oral formulation; M.V.I.-12 is for IV use only.
No dose adjustment required; M.V.I. Adult is a multivitamin formulation with no excipients requiring renal adjustment.
No specific dose adjustment required for renal impairment.
Caution in severe hepatic impairment (Child-Pugh Class C); monitor for vitamin accumulation, particularly fat-soluble vitamins. No specific dose adjustment established.
No specific dose adjustment required for hepatic impairment.
Not recommended for use in children; alternative pediatric formulations are available.
For children weighing <40 kg: 0.25 mL/kg/day (max 10 mL) intravenously once daily. For children weighing ≥40 kg: same as adult dose (10 mL once daily).
No specific dose adjustment required; use standard adult dosing with monitoring for vitamin levels and renal function.
Standard adult dosing; no specific geriatric adjustment required.
None.
None.
["Allergic reactions have been reported, especially with vitamin B1 (thiamine) and B12.","Aluminum toxicity: Contains aluminum, which may be toxic with prolonged use in renal impairment.","Reduce dosage in patients with liver disease or cholestasis.","Folic acid may mask vitamin B12 deficiency.","Ensure adequate hydration to avoid crystallization of vitamins in urine."]
["Hypersensitivity reactions may occur, especially in patients with allergies to thiamine or other components.","Monitor for signs of vitamin toxicity, particularly vitamins A and D.","Use with caution in patients with renal impairment due to potential accumulation of fat-soluble vitamins.","Administer only as an additive to intravenous fluids; do not give as a direct infusion."]
["Hypersensitivity to any component.","Pre-existing hypervitaminosis (e.g., vitamin A or D toxicity).","Patients with severe hepatic impairment or cholestasis (for vitamin K-containing product).","Concurrent use with certain drugs (e.g., methotrexate high dose due to folic acid antagonism)."]
["Hypersensitivity to any component of the formulation.","Patients with preexisting hypervitaminosis."]
Data Pending Review
Data Pending Review
No specific food interactions, but as part of parenteral nutrition, oral diet should be coordinated with clinical nutrition team.
No direct food interactions known as the drug is administered intravenously. However, patients on parenteral nutrition may have dietary restrictions based on underlying condition (e.g., renal, hepatic). Vitamin K content may affect warfarin therapy; monitor INR if applicable.
M.V.I. Adult is a multivitamin formulation containing vitamins A, D, E, K, C, B1, B2, B3, B6, B9, B12, and B5. Therapeutic doses of individual vitamins generally have low teratogenic risk; however, excessive vitamin A (retinol) >10,000 IU/day is teratogenic (first trimester: CNS, cardiac, facial defects; second/third trimester: no increased risk with supplementation within RDA). Vitamin D excess may cause hypercalcemia and fetal anomalies. Folic acid (vitamin B9) is protective against neural tube defects. Overall, at recommended doses, the teratogenic risk profile is low, with specific risks only at supratherapeutic levels.
M.V.I.-12 Lyophilized contains vitamins A, D, E, K, C, B1, B2, B3, B5, B6, B9, B12. Vitamin A at high doses (>10,000 IU/day) is teratogenic in first trimester. Vitamin D excessive doses may cause fetal hypercalcemia. Vitamin K at high doses may increase neonatal jaundice risk. Folic acid supplementation is beneficial for neural tube defect prevention. Individual vitamin components should be reviewed; the combination product at recommended doses is generally considered low risk but requires monitoring of vitamin A and D levels.
Vitamins in M.V.I. Adult are excreted into breast milk; at recommended doses, they are considered compatible with breastfeeding. No adverse effects reported in nursing infants. The milk-to-plasma (M/P) ratio is not established for the combination product. Fat-soluble vitamins (A, D, E, K) achieve higher milk concentrations with maternal supplementation, but at RDA levels, infant exposure is within safe limits. Monitor infant for signs of toxicity only if maternal intake exceeds RDA.
Most components are excreted into breast milk, but the product at recommended doses is compatible with breastfeeding. The milk-to-plasma ratio varies by component; for example, vitamin A M/P ratio is approximately 0.5-0.7, vitamin D is low. High doses of vitamin A or D may accumulate in infant and should be avoided. Caution with vitamin K if infant has deficiency or bleeding risk.
No adjustment in dosage is required during pregnancy when used at the recommended daily allowance for pregnant women. Pregnancy increases the demand for certain vitamins (e.g., folate, iron, vitamin D) but M.V.I. Adult provides standard amounts; specific deficiencies may require additional supplementation. No pharmacokinetic changes necessitate dose reduction.
No specific dose adjustments required for pregnancy; use standard dosing. Ensure that vitamin A does not exceed 10,000 IU/day to avoid teratogenicity. Monitor for increased needs of folic acid (400-800 mcg/day) and iron (if part of separate regimen). Pharmacokinetic changes in pregnancy (e.g., increased plasma volume) do not necessitate dose changes for this multivitamin product.
Category C
Category C
M.V.I. Adult is a multivitamin infusion indicated for parenteral nutrition. Monitor for hypersensitivity reactions, especially in patients with allergies to vitamin B1 or folic acid. Protect from light during administration due to photosensitivity of vitamins. Do not exceed recommended infusion rates to avoid phlebitis.
M.V.I.-12 Lyophilized is a multivitamin formulation for intravenous infusion in patients requiring parenteral nutrition. It contains 12 vitamins (including fat-soluble A, D, E, K and water-soluble B complex, C). Monitor for allergic reactions, especially in patients with thiamine (B1) sensitivity. Add to IV fluids just before administration; protect from light to prevent degradation. Do not exceed recommended dose; avoid rapid infusion. Caution in patients with renal impairment or electrolyte imbalances due to additives.
This medication is a vitamin supplement given intravenously as part of your nutrition therapy.Inform your healthcare provider if you have a history of allergic reactions to any vitamins.Report any symptoms such as rash, itching, or difficulty breathing during the infusion.This product contains vitamin K; inform your doctor if you take blood thinners like warfarin.
This medication is used to provide essential vitamins when you cannot eat or drink normally.It is given through a vein (IV) and must be infused slowly.Report any signs of allergic reaction such as rash, itching, swelling, or trouble breathing immediately.Tell your doctor if you have kidney problems or any food allergies.Do not use this product if it is discolored or contains particles.